We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Intra-Operative Electron Boost and Hypofractionated Whole-Breast Irradiation During Breast-conserving Treatment (BCT) (HIOB)

This study is currently recruiting participants.
Verified June 2017 by Prof. Sedlmayer, Paracelsus Medical University
Sponsor:
ClinicalTrials.gov Identifier:
NCT01343459
First Posted: April 28, 2011
Last Update Posted: June 5, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
Collaborators:
LKH Klagenfurt
Poznan University of Medical Sciences
San Filippo Neri General Hospital
Avera McKennan Hospital & University Health Center
St. Luke’s Hospital ,Cedar Rapids, US
A.O.U. San Giovanni Battista di Torino, Italy
IRCCS Cancer Referral Center of Basilicata
Heinrich-Heine University, Duesseldorf
St. Elisabeth-Hospital Köln-Hohenlind, Germany
S.C. Radiotherapia Aziendale Umbria, Italy
Azienda Ospedaliero, Universitaria Ospedali Riuniti
Fondazione Salvatore Maugeri
Marien Hospital Düsseldorf, Germany
Azienda Ospedaliero Universitaria Maggiore della Carita
Philipps University Marburg Medical Center
Istituti Tumori Giovanni Paolo II
Information provided by (Responsible Party):
Prof. Sedlmayer, Paracelsus Medical University
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: May 2021
  Estimated Primary Completion Date: March 2021 (Final data collection date for primary outcome measure)